Literature DB >> 12751504

Medicaid prescription drug coverage: state efforts to control costs.

Dawn M Gencarelli.   

Abstract

This paper provides a brief summary of the Medicaid prescription drug benefit. It explains the mechanisms being used by states to control their prescription drug spending within the Medicaid program. The paper also highlights some of the concerns that have been expressed with these mechanisms and the litigation that has been initiated in several states as a result of these efforts. It takes a closer look at three states with cost-containment strategies that have been the focus of increased scrutiny.

Mesh:

Substances:

Year:  2003        PMID: 12751504

Source DB:  PubMed          Journal:  NHPF Issue Brief


  6 in total

1.  State Investments in Psychiatric Innovation: Investigating Unmeasured State Factors.

Authors:  Marisa Elena Domino; Christopher Alan Beadles
Journal:  Health Serv Outcomes Res Methodol       Date:  2014-06-01

2.  Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.

Authors:  Seung Jin Bae; A David Paltiel; Anne L Fuhlbrigge; Scott T Weiss; Karen M Kuntz
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

Review 3.  Making a case for employing a societal perspective in the evaluation of Medicaid prescription drug interventions.

Authors:  Sanjoy Roy; S Suresh Madhavan
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Integrating substance abuse treatment into HIV care: missed opportunities in the AIDS Drug Assistance Program.

Authors:  Erika G Martin; Karen H Wang
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

Review 5.  Preferred drug lists: potential impact on healthcare economics.

Authors:  Kimberly Ovsag; Sabrina Hydery; Shaker A Mousa
Journal:  Vasc Health Risk Manag       Date:  2008

6.  Prescription drug benefits: cost management issues for Medicare.

Authors:  Peter D Fox
Journal:  Health Care Financ Rev       Date:  2003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.